Accenture plc (ACN) Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD 2019 - 2023

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
Summary
Accenture plc quarterly Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect history and growth rate from 2019 to 2023.
  • Accenture plc Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect for the quarter ending November 30, 2023 was -$1.9B, a 4.32% increase year-over-year.
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, Trailing 12 Months (USD)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, Quarterly Data (USD)
Period Value YoY Chg Change % Start Date End Date Report Filed
Q4 2023 -$1.9B +$85.9M +4.32% Sep 1, 2023 Nov 30, 2023 10-Q 2023-12-19
Q3 2023 $1.16B +$1.43B Sep 1, 2022 Aug 31, 2023 10-K 2023-10-12
Q4 2022 -$1.99B +$541M +21.4% Sep 1, 2022 Nov 30, 2022 10-Q 2023-12-19
Q3 2022 -$278M -$31.2M -12.6% Sep 1, 2021 Aug 31, 2022 10-K 2023-10-12
Q4 2021 -$2.53B -$2.71B -1517% Sep 1, 2021 Nov 30, 2021 10-Q 2022-12-16
Q3 2021 -$247M -$2.54B -111% Sep 1, 2020 Aug 31, 2021 10-K 2023-10-12
Q4 2020 $179M +$495M Sep 1, 2020 Nov 30, 2020 10-Q 2021-12-16
Q3 2020 $2.29B +$1.22B +115% Sep 1, 2019 Aug 31, 2020 10-K 2022-10-12
Q4 2019 -$316M Sep 1, 2019 Nov 30, 2019 10-Q 2020-12-17
Q3 2019 $1.07B Sep 1, 2018 Aug 31, 2019 10-K 2021-10-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.